September 1, 2026 – Seoul, Korea: RGCC International, a global leader in circulating tumor cell (CTC) testing and personalized oncology, announced the signing of a distributorship agreement with VanH (Good Aging Research Center), a leading Korean functional medicine institution. The Memorandum of Understanding (MOU) was signed on August 31, 2026, in Seoul, Korea, by Mikhail Kiang, RGCC Global, and Dr. Lee Jae Chul, VanH, marking a significant step in bringing advanced, personalized cancer care technologies to the Korean market.
The partnership pairs RGCC's two decades of scientific expertise in personalized diagnostics with VanH's extensive clinical network and deep understanding of the Korean healthcare landscape, laying the groundwork for an individualized, patient-centered approach to cancer care in Korea.
Beyond clinical application, the collaboration will promote physician education through training, case-based learning and collaborative research, initiatives designed to strengthen clinicians' ability to interpret CTC-based data and to evaluate how such insights may be appropriately integrated into existing oncology and supportive-care pathways within the Korean healthcare system.
The partnership aims to expand access for cancer patients in Korea to personalized supportive approaches, including early cancer detection and a deeper understanding of individual tumor biology, treatment response, and supportive interventions alongside established oncology care.
About RGCC International:
RGCC was launched in 2004 by genetics pioneer Dr. Ioannis Papasotiriou who believes that the key to effectively treating cancer lies in personalized medicine. Today, RGCC is a leading innovator in the field of oncology diagnostics. Using world-leading technology, equipment, and innovative techniques, our team of scientists has developed a range of liquid biopsies that help physicians track cancer progression and tailor treatment plans based on individual patient profiles.
About VanH:
VanH was founded by Dr. Lee Jae Chul, a pain medicine specialist and respected leader within Korea’s functional medicine community. Throughout his career, Dr. Lee has held several senior professional positions and remained a dedicated advocate for the advancement of functional medicine. In 2020, he was appointed President of the Korean Functional Medicine Society, and he now continues to contribute to the Society as an advisor.
Today, VanH is recognised as one of Korea’s pioneering medical institutions dedicated to functional medicine. Guided by a strong clinical philosophy, the clinic has cared for a substantial number of patients since its establishment. Through its extensive clinical experience and patient-centred approach, VanH continues to advance the practice of personalized functional medicine in Korea.